State-of-the-art in Metastatic Uveal Melanoma Treatment: A 2025 Update : How to treat Metastatic Uveal Melanoma in 2025.

Curr Oncol Rep · 2025 · PMC12328531 · PMID 40380030

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

marginally significantP = 0.052so close (0.05 < p ≤ 0.1)

Furthermore, chromosome 8p loss (HR: 1.97; 95%CI: 1.03–3.77, P = 0.04) and 8q gain are also associated with a grave prognosis, although the latter was marginally significant (HR: 2.30; 95%CI: 0.99–5.30, P = 0.052) [ 25 ].

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.